A Real-World, Single-Center, Observational Retrospective Experience of Durvalumab Treatment After Concomitant Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.

Cancers (Basel) · 2026 · PMC13025999 · PMID 41899644

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

showed a trendp = 0.068so close (0.05 < p ≤ 0.1)

At the same time, PD-L1(+) showed a trend toward longer PFS (HR = 0.24; p = 0.068), but the analysis was limited by the small number of events and wide confidence intervals.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.